RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy

Beth D. Kaufman, Scott Auerbach, Sushma Reddy, Cedric Manlhiot, Liyong Deng, Ashwin Prakash, Beth F. Printz, Dorota Gruber, Dimitrios P. Papavassiliou, Daphne T. Hsu, Amy J. Sehnert, Wendy K. Chung, Seema Mital

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Hypertrophic Cardiomyopathy (HCM) is a disease with variable rate of progression. Young age is an independent risk factor for poor outcome in HCM. The influence of renin-angiotensin-aldosterone (RAAS) genotype on the progression of HCM in children is unknown. Children with HCM (n = 65) were enrolled prospectively across two centers (2001-2005). All subjects were genotyped for five RAAS gene polymorphisms previously associated with LV hypertrophy (pro-LVH): AGT M235T, ACE DD, CMA-1903 A/G, AGTR11666 A/C and CYP11B2 -344 C/T. Linear regression models, based on maximum likelihood estimates, were created to assess the independent effect of RAAS genotype on LV hypertrophy (LVH). Forty-six subjects were homozygous for <2 and 19 were homozygous for ≥2 pro-LVH RAAS polymorphisms. Mean age at presentation was 9.6 ± 6 years. Forty children had follow-up echocardiograms after a median of 1.5 years. Indexed LV mass (LVMI) and LV mass z-scores were higher at presentation and follow-up in subjects with ≥2 pro-LVH genotypes compared to those with <2 (P < 0.05). Subjects with <2 pro-LVH genotypes also demonstrated a greater increase in septal thickness (IVST) and in LV outflow tract (LVOT) obstruction on follow-up (P < 0.05). On multivariate analysis, a higher number of pro-LVH genotypes was associated with a larger effect size (P < 0.05). Pro-LVH RAAS gene polymorphisms are associated with progressive septal hypertrophy and LVOT obstruction in children with HCM. Identification of RAAS modifier genes may help to risk-stratify patients with HCM.

Original languageEnglish (US)
Pages (from-to)515-523
Number of pages9
JournalHuman Genetics
Volume122
Issue number5
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Hypertrophic Cardiomyopathy
Angiotensins
Aldosterone
Renin
Hypertrophy
Pediatrics
Genes
Genotype
Linear Models
Cytochrome P-450 CYP11B2
Modifier Genes
Likelihood Functions
Multivariate Analysis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Kaufman, B. D., Auerbach, S., Reddy, S., Manlhiot, C., Deng, L., Prakash, A., ... Mital, S. (2007). RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Human Genetics, 122(5), 515-523. https://doi.org/10.1007/s00439-007-0429-9

RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. / Kaufman, Beth D.; Auerbach, Scott; Reddy, Sushma; Manlhiot, Cedric; Deng, Liyong; Prakash, Ashwin; Printz, Beth F.; Gruber, Dorota; Papavassiliou, Dimitrios P.; Hsu, Daphne T.; Sehnert, Amy J.; Chung, Wendy K.; Mital, Seema.

In: Human Genetics, Vol. 122, No. 5, 12.2007, p. 515-523.

Research output: Contribution to journalArticle

Kaufman, BD, Auerbach, S, Reddy, S, Manlhiot, C, Deng, L, Prakash, A, Printz, BF, Gruber, D, Papavassiliou, DP, Hsu, DT, Sehnert, AJ, Chung, WK & Mital, S 2007, 'RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy', Human Genetics, vol. 122, no. 5, pp. 515-523. https://doi.org/10.1007/s00439-007-0429-9
Kaufman BD, Auerbach S, Reddy S, Manlhiot C, Deng L, Prakash A et al. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Human Genetics. 2007 Dec;122(5):515-523. https://doi.org/10.1007/s00439-007-0429-9
Kaufman, Beth D. ; Auerbach, Scott ; Reddy, Sushma ; Manlhiot, Cedric ; Deng, Liyong ; Prakash, Ashwin ; Printz, Beth F. ; Gruber, Dorota ; Papavassiliou, Dimitrios P. ; Hsu, Daphne T. ; Sehnert, Amy J. ; Chung, Wendy K. ; Mital, Seema. / RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. In: Human Genetics. 2007 ; Vol. 122, No. 5. pp. 515-523.
@article{b341060d1708409aa505b65ec8247797,
title = "RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy",
abstract = "Hypertrophic Cardiomyopathy (HCM) is a disease with variable rate of progression. Young age is an independent risk factor for poor outcome in HCM. The influence of renin-angiotensin-aldosterone (RAAS) genotype on the progression of HCM in children is unknown. Children with HCM (n = 65) were enrolled prospectively across two centers (2001-2005). All subjects were genotyped for five RAAS gene polymorphisms previously associated with LV hypertrophy (pro-LVH): AGT M235T, ACE DD, CMA-1903 A/G, AGTR11666 A/C and CYP11B2 -344 C/T. Linear regression models, based on maximum likelihood estimates, were created to assess the independent effect of RAAS genotype on LV hypertrophy (LVH). Forty-six subjects were homozygous for <2 and 19 were homozygous for ≥2 pro-LVH RAAS polymorphisms. Mean age at presentation was 9.6 ± 6 years. Forty children had follow-up echocardiograms after a median of 1.5 years. Indexed LV mass (LVMI) and LV mass z-scores were higher at presentation and follow-up in subjects with ≥2 pro-LVH genotypes compared to those with <2 (P < 0.05). Subjects with <2 pro-LVH genotypes also demonstrated a greater increase in septal thickness (IVST) and in LV outflow tract (LVOT) obstruction on follow-up (P < 0.05). On multivariate analysis, a higher number of pro-LVH genotypes was associated with a larger effect size (P < 0.05). Pro-LVH RAAS gene polymorphisms are associated with progressive septal hypertrophy and LVOT obstruction in children with HCM. Identification of RAAS modifier genes may help to risk-stratify patients with HCM.",
author = "Kaufman, {Beth D.} and Scott Auerbach and Sushma Reddy and Cedric Manlhiot and Liyong Deng and Ashwin Prakash and Printz, {Beth F.} and Dorota Gruber and Papavassiliou, {Dimitrios P.} and Hsu, {Daphne T.} and Sehnert, {Amy J.} and Chung, {Wendy K.} and Seema Mital",
year = "2007",
month = "12",
doi = "10.1007/s00439-007-0429-9",
language = "English (US)",
volume = "122",
pages = "515--523",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy

AU - Kaufman, Beth D.

AU - Auerbach, Scott

AU - Reddy, Sushma

AU - Manlhiot, Cedric

AU - Deng, Liyong

AU - Prakash, Ashwin

AU - Printz, Beth F.

AU - Gruber, Dorota

AU - Papavassiliou, Dimitrios P.

AU - Hsu, Daphne T.

AU - Sehnert, Amy J.

AU - Chung, Wendy K.

AU - Mital, Seema

PY - 2007/12

Y1 - 2007/12

N2 - Hypertrophic Cardiomyopathy (HCM) is a disease with variable rate of progression. Young age is an independent risk factor for poor outcome in HCM. The influence of renin-angiotensin-aldosterone (RAAS) genotype on the progression of HCM in children is unknown. Children with HCM (n = 65) were enrolled prospectively across two centers (2001-2005). All subjects were genotyped for five RAAS gene polymorphisms previously associated with LV hypertrophy (pro-LVH): AGT M235T, ACE DD, CMA-1903 A/G, AGTR11666 A/C and CYP11B2 -344 C/T. Linear regression models, based on maximum likelihood estimates, were created to assess the independent effect of RAAS genotype on LV hypertrophy (LVH). Forty-six subjects were homozygous for <2 and 19 were homozygous for ≥2 pro-LVH RAAS polymorphisms. Mean age at presentation was 9.6 ± 6 years. Forty children had follow-up echocardiograms after a median of 1.5 years. Indexed LV mass (LVMI) and LV mass z-scores were higher at presentation and follow-up in subjects with ≥2 pro-LVH genotypes compared to those with <2 (P < 0.05). Subjects with <2 pro-LVH genotypes also demonstrated a greater increase in septal thickness (IVST) and in LV outflow tract (LVOT) obstruction on follow-up (P < 0.05). On multivariate analysis, a higher number of pro-LVH genotypes was associated with a larger effect size (P < 0.05). Pro-LVH RAAS gene polymorphisms are associated with progressive septal hypertrophy and LVOT obstruction in children with HCM. Identification of RAAS modifier genes may help to risk-stratify patients with HCM.

AB - Hypertrophic Cardiomyopathy (HCM) is a disease with variable rate of progression. Young age is an independent risk factor for poor outcome in HCM. The influence of renin-angiotensin-aldosterone (RAAS) genotype on the progression of HCM in children is unknown. Children with HCM (n = 65) were enrolled prospectively across two centers (2001-2005). All subjects were genotyped for five RAAS gene polymorphisms previously associated with LV hypertrophy (pro-LVH): AGT M235T, ACE DD, CMA-1903 A/G, AGTR11666 A/C and CYP11B2 -344 C/T. Linear regression models, based on maximum likelihood estimates, were created to assess the independent effect of RAAS genotype on LV hypertrophy (LVH). Forty-six subjects were homozygous for <2 and 19 were homozygous for ≥2 pro-LVH RAAS polymorphisms. Mean age at presentation was 9.6 ± 6 years. Forty children had follow-up echocardiograms after a median of 1.5 years. Indexed LV mass (LVMI) and LV mass z-scores were higher at presentation and follow-up in subjects with ≥2 pro-LVH genotypes compared to those with <2 (P < 0.05). Subjects with <2 pro-LVH genotypes also demonstrated a greater increase in septal thickness (IVST) and in LV outflow tract (LVOT) obstruction on follow-up (P < 0.05). On multivariate analysis, a higher number of pro-LVH genotypes was associated with a larger effect size (P < 0.05). Pro-LVH RAAS gene polymorphisms are associated with progressive septal hypertrophy and LVOT obstruction in children with HCM. Identification of RAAS modifier genes may help to risk-stratify patients with HCM.

UR - http://www.scopus.com/inward/record.url?scp=36348958409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348958409&partnerID=8YFLogxK

U2 - 10.1007/s00439-007-0429-9

DO - 10.1007/s00439-007-0429-9

M3 - Article

C2 - 17851694

AN - SCOPUS:36348958409

VL - 122

SP - 515

EP - 523

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 5

ER -